Bleakley Financial Group’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,200
Closed -$9.5K 1064
2024
Q2
$9.5K Hold
1,200
﹤0.01% 1007
2024
Q1
$16.3K Hold
1,200
﹤0.01% 986
2023
Q4
$13K Hold
1,200
﹤0.01% 945
2023
Q3
$7.8K Hold
1,200
﹤0.01% 881
2023
Q2
$21.6K Hold
1,200
﹤0.01% 916
2023
Q1
$28.2K Hold
1,200
﹤0.01% 888
2022
Q4
$30K Buy
+1,200
New +$30K ﹤0.01% 851